Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer
Autor: | Eymard, J-C *, Priou, F., Zannetti, A., Ravaud, A., Lepillé, D., Kerbrat, P., Gomez, P., Paule, B., Genet, D., Hérait, P., Ecstein-Fraïssé, E., Joly, F. |
---|---|
Zdroj: | In Annals of Oncology June 2007 18(6):1064-1070 |
Databáze: | ScienceDirect |
Externí odkaz: |